Literature DB >> 16962556

Exploring "one-shot" kinetics and small molecule analysis using the ProteOn XPR36 array biosensor.

Tsafrir Bravman1, Vered Bronner, Kobi Lavie, Ariel Notcovich, Giuseppe A Papalia, David G Myszka.   

Abstract

A ProteOn XPR36 parallel array biosensor was used to characterize the binding kinetics of a set of small molecule/enzyme interactions. Using one injection with the ProteOn's crisscrossing flow path system, we collected response data for six different concentrations of each analyte over six different target protein surfaces. This "one-shot" approach to kinetic analysis significantly improves throughput while generating high-quality data even for low-molecular-mass analytes. We found that the affinities determined for nine sulfonamide-based inhibitors of the enzyme carbonic anhydrase II were highly correlated with the values determined using isothermal titration calorimetry. We also measured the temperature dependence (from 15 to 35 degrees C) of the kinetics for four of the inhibitor/enzyme interactions. Our results illustrate the potential of this new parallel-processing biosensor to increase the speed of kinetic analysis in drug discovery and expand the applications of real-time protein interaction arrays.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16962556     DOI: 10.1016/j.ab.2006.08.005

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  57 in total

1.  Nonlinear analyte concentration gradients for one-step kinetic analysis employing optical microring resonators.

Authors:  Michael T Marty; Courtney D Kuhnline Sloan; Ryan C Bailey; Stephen G Sligar
Journal:  Anal Chem       Date:  2012-06-22       Impact factor: 6.986

2.  pH-dependent binding engineering reveals an FcRn affinity threshold that governs IgG recycling.

Authors:  M Jack Borrok; Yanli Wu; Nurten Beyaz; Xiang-Qing Yu; Vaheh Oganesyan; William F Dall'Acqua; Ping Tsui
Journal:  J Biol Chem       Date:  2014-12-23       Impact factor: 5.157

3.  Exploring Modifications of an HIV-1 Capsid Inhibitor: Design, Synthesis, and Mechanism of Action.

Authors:  Jimmy P Xu; Ashwanth C Francis; Megan E Meuser; Marie Mankowski; Roger G Ptak; Adel A Rashad; Gregory B Melikyan; Simon Cocklin
Journal:  J Drug Des Res       Date:  2018-08-13

4.  Restricted V gene usage and VH/VL pairing of mouse humoral response against the N-terminal immunodominant epitope of the amyloid β peptide.

Authors:  Remy Robert; Marie-Paule Lefranc; Anahit Ghochikyan; Michael G Agadjanyan; David H Cribbs; William E Van Nostrand; Kim L Wark; Olan Dolezal
Journal:  Mol Immunol       Date:  2010 Nov-Dec       Impact factor: 4.407

5.  Single nucleotide polymorphisms in the FcγR3A and TAP1 genes impact ADCC in cynomolgus monkey PBMCs.

Authors:  Jonathan C Sanford; Hong Wu; Yasmina Abdiche; Julie A Harney; Javier Chaparro-Riggers; Karissa Adkins
Journal:  Immunogenetics       Date:  2017-02-03       Impact factor: 2.846

6.  Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities.

Authors:  Lin Sun; Alexej Dick; Megan E Meuser; Tianguang Huang; Waleed A Zalloum; Chin-Ho Chen; Srinivasulu Cherukupalli; Shujing Xu; Xiao Ding; Ping Gao; Dongwei Kang; Erik De Clercq; Christophe Pannecouque; Simon Cocklin; Kuo-Hsiung Lee; Xinyong Liu; Peng Zhan
Journal:  J Med Chem       Date:  2020-04-29       Impact factor: 7.446

7.  Analysis of the activities of RAD54, a SWI2/SNF2 protein, using a specific small-molecule inhibitor.

Authors:  Julianna S Deakyne; Fei Huang; Joseph Negri; Nicola Tolliday; Simon Cocklin; Alexander V Mazin
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

8.  Germline humanization of a murine Abeta antibody and crystal structure of the humanized recombinant Fab fragment.

Authors:  Remy Robert; Victor A Streltsov; Janet Newman; Lesley A Pearce; Kim L Wark; Olan Dolezal
Journal:  Protein Sci       Date:  2010-02       Impact factor: 6.725

9.  Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compounds.

Authors:  Giorgio Colombo; Barbara Margosio; Laura Ragona; Marco Neves; Silvia Bonifacio; Douglas S Annis; Matteo Stravalaci; Simona Tomaselli; Raffaella Giavazzi; Marco Rusnati; Marco Presta; Lucia Zetta; Deane F Mosher; Domenico Ribatti; Marco Gobbi; Giulia Taraboletti
Journal:  J Biol Chem       Date:  2010-01-07       Impact factor: 5.157

10.  Immunopurification of pathological prion protein aggregates.

Authors:  Emiliano Biasini; Laura Tapella; Susanna Mantovani; Matteo Stravalaci; Marco Gobbi; David A Harris; Roberto Chiesa
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.